Finance

Lists
PVCT:OTCMKTS
Provectus Biopharmaceuticals Inc
0,053 $
-0,28%
(-0,00015) 1D
6 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVCT...
Open
0,05 $
High
0,05 $
Low
0,05 $
Mkt. cap
24,24 млн
Avg. vol.
137,54 м.
Volume
33,64 мың
52-wk high
0,08 $
52-wk low
0,04 $
EPS
-0,01 $
Beta
0,91
Shares outstanding
420,28 млн
No. of employees
6
Open
0,05 $
High
0,05 $
Low
0,05 $
Mkt. cap
24,24 млн
Avg. vol.
137,54 м.
Volume
33,64 мың
52-wk high
0,08 $
52-wk low
0,04 $
EPS
-0,01 $
Beta
0,91
Shares outstanding
420,28 млн
No. of employees
6
News stories
From web sources and news partners
About Provectus Biopharmaceuticals Inc
CEO-
Employees6
Founded2002
HeadquartersНоксвилл, Теннесси, Америка Құрама Штаттары
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
323,22 м.
248,94 м.
324,27 м.
121,55 м.
Cost of revenue
323,22 м.
248,94 м.
324,27 м.
121,55 м.
Research and development expenses
13,64 мың
13,64 мың
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
831,08 м.
761,24 м.
923,63 м.
737,40 м.
Operating expense
844,72 м.
774,88 м.
923,63 м.
737,40 м.
Total operating expenses
1,17 млн
1,02 млн
1,25 млн
858,95 м.
Operating income
-1,17 млн
-1,02 млн
-1,25 млн
-858,95 м.
Other non operating income
-
-
-
-
EBT including unusual items
-1,32 млн
-1,17 млн
-1,30 млн
-988,72 м.
EBT excluding unusual items
-1,22 млн
-1,07 млн
-1,30 млн
-909,27 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,31 млн
-1,17 млн
-1,29 млн
-982,57 м.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-48,02 мың
-47,32 мың
-53,05 мың
-50,32 мың
Net interest expenses
-48,02 мың
-47,32 мың
-53,05 мың
-50,32 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,17 млн
-1,02 млн
-1,25 млн
-858,48 м.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары